Risk factors and prodromal markers and the development of Parkinson’s disease

被引:0
|
作者
Stefanie Lerche
Klaus Seppi
Stefanie Behnke
Inga Liepelt-Scarfone
Jana Godau
Philipp Mahlknecht
Alexandra Gaenslen
Kathrin Brockmann
Karin Srulijes
Heiko Huber
Isabel Wurster
Heike Stockner
Stefan Kiechl
Johann Willeit
Arno Gasperi
Klaus Fassbender
Werner Poewe
Daniela Berg
机构
[1] University of Tuebingen,Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology
[2] University of Tuebingen,German Center for Neurodegenerative Diseases (DZNE)
[3] University of Innsbruck,Department of Neurology
[4] University of Homburg/Saar,Department of Neurology
[5] Bruneck Hospital,Department of Neurology
来源
Journal of Neurology | 2014年 / 261卷
关键词
Risk factor; Prodromal marker; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Identification of risk factors and prodromal markers for Parkinson’s disease (PD) and the understanding of the point in time of first occurrence is essential for the early detection of incident PD. In this three-center longitudinal, observational study, we evaluated the specific risk for PD associated with single or combinations of risk factors and prodromal markers. In addition, we evaluated which risk factors and prodromal markers emerge at which time before the diagnosis of PD. Of the 1,847 at-baseline PD-free individuals ≥50 years, 1,260 underwent the 5-year follow-up assessment. There were 21 cases of incident PD during the study period. Enlarged hyperechogenic substantia nigra was the most frequent baseline sign in individuals developing PD after 3 years (80.0 %) and 5 years (85.7 %) compared to healthy controls (17.5 %) followed by the occurrence of mild parkinsonian signs and hyposmia. Evaluation of the signs at the first follow-up assessment showed that individuals developing PD after two additional years showed the same pattern of signs as individuals who developed PD 3 years after baseline assessment.
引用
收藏
页码:180 / 187
页数:7
相关论文
共 50 条
  • [41] Challenges in identifying genetic markers of susceptibility to environmental risk factors for Parkinson's disease
    Checkoway, H
    EPIDEMIOLOGY, 2000, 11 (04) : S148 - S148
  • [42] Editor's note: Prodromal Parkinson's disease
    Obeso, Jose A.
    MOVEMENT DISORDERS, 2019, 34 (05) : 664 - 664
  • [43] Cognition and the Course of Prodromal Parkinson's Disease
    Weintraub, Daniel
    Chahine, Lana M.
    Hawkins, Keith A.
    Siderowf, Andrew
    Eberly, Shirley
    Oakes, David
    Seibyl, John
    Stern, Matthew B.
    Marek, Kenneth
    Jennings, Danna
    MOVEMENT DISORDERS, 2017, 32 (11) : 1640 - 1645
  • [44] On the Emergence of Tremor in Prodromal Parkinson's Disease
    Fearon, Conor
    Lees, Andrew J.
    McKinley, John J.
    McCarthy, Allan
    Smyth, Shane
    Farrell, Michael
    Lynch, Timothy
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (01) : 261 - 269
  • [45] Neuropsychological impairment in prodromal Parkinson's disease
    Pausch, Christoph
    Schomburg, Robert
    Wagenpfeil, Stefan
    Wollenweber, Frank Arne
    Bayer, Caroline
    Fassbender, Klaus
    Behnke, Stefanie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 371 : 117 - 120
  • [46] Animal Model for Prodromal Parkinson's Disease
    Taguchi, Tomoyuki
    Ikuno, Masashi
    Yamakado, Hodaka
    Takahashi, Ryosuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [47] Constipation with selected prodromal features increases risk of subsequent Parkinson's disease
    Brown, E.
    Goldman, S.
    Albers, K.
    VanDen Eeden, S.
    Tanner, C.
    MOVEMENT DISORDERS, 2019, 34 : S324 - S325
  • [48] Biofluid Biomarkers in Prodromal Parkinson's Disease
    Mollenhauer, B.
    Chahine, L.
    Dakna, M.
    Bartl, M.
    Siderowf, A.
    Hutten, S. J.
    Merchant, K.
    Marek, K.
    Galasko, D.
    MOVEMENT DISORDERS, 2021, 36 : S339 - S339
  • [49] Tracking the course of prodromal Parkinson's disease
    Breen, David P.
    Lang, Anthony E.
    BRAIN, 2017, 140 (02) : 259 - 262
  • [50] Tracking the course of prodromal Parkinson's disease
    Breen, David P.
    Lang, Anthony E.
    BRAIN, 2017, 140 : 259 - 262